StrideBio was founded based on technologies and intellectual property from Dr. Aravind Asokan’s lab at the University of North Carolina at Chapel Hill and Dr. Mavis Agbangje-McKenna’s lab at the University of Florida. StrideBio is developing engineered viral vectors for gene therapy using structure-inspired design of adeno-associated virus (AAV) vectors that can evade neutralizing antibodies
Acquired by Ginkgo Bioworks 2023
